Literature DB >> 33516666

The protective role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under inflammatory environment.

Fang Qu1, Yingshuang Song1, Yaqin Wu1, Yujie Huang1, Qi Zhong1, Yifan Zhang1, Zhen Fan2, Chun Xu3.   

Abstract

Inflammation and alveolar bone destruction constitute the main pathological process of periodontitis. However, the molecular mechanisms of bone destruction under the inflammation environment remain unclear. This study aims to explore the role of Ephrin-B2/EphB4 signaling in osteogenic differentiation under the inflammation environment. Mouse pre-osteoblasts MC3T3-E1 were pretreated with lipopolysaccharide of Porphyromonas gingivalis (Pg-LPS). The Ephrin-B2/EphB4 signaling was activated, and the osteogenic differentiation of cells was examined. The results showed that activation of Ephrin-B2/EphB4 signaling promoted the expression levels of osteogenic differentiation-related genes, and also relieved the inhibitory effect of Pg-LPS on osteogenesis. Noticeably, the effect of Ephrin-B2/EphB4 signaling might be related to the mitogen-activated protein kinase (MAPK) pathway. While applying Ephrin-B2-Fc and EphB4-Fc to periodontitis mice, we observed the reduction of alveolar crest destruction. The current study revealed the possible role of Ephrin-B2/EphB4 signaling in reducing bone destruction in periodontitis and suggested its potential values for further research.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ephrin-B2/EphB4; Inflammation; Osteogenesis; Periodontitis; Signal transduction

Year:  2021        PMID: 33516666     DOI: 10.1016/j.yexcr.2021.112505

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  1 in total

1.  Role of EphB2/ephrin-B1 signalling in the development and progression of obesity-associated colorectal cancer.

Authors:  Yoshiyuki Suzuki; Koji Okabayashi; Hirotoshi Hasegawa; Masashi Tsuruta; Ryo Seishima; Toshiki Tokuda; Yuko Kitagawa
Journal:  Oncol Lett       Date:  2022-07-19       Impact factor: 3.111

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.